GlassScriptPhysician profile
Monique G Monard
NPI 1164953022
$1,784.15
in general payments reported to CMS, 2019-2025
25 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $244 · 2023: $565 · 2024: $620 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $247.63 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $190.53 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $132.06 | 2023-2024 | Myfembree |
| Abbvie INC. | $128.38 | 2021-2023 | |
| Myriad Women'S Health, INC. | $108.22 | 2023 | Myrisk |
| Myovant Sciences INC. | $103.77 | 2021 | |
| Intuitive Surgical, INC. | $97.67 | 2022 | |
| Pfizer INC. | $94.70 | 2022-2024 | |
| Hologic Sales and Service, LLC | $76.63 | 2023 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Axonics, INC. | $66.83 | 2022 | |
| Exact Sciences Corporation | $64.15 | 2023-2024 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $58.69 | 2023-2024 | Twirla |
| Shield Therapeutics INC | $50.19 | 2024-2025 | |
| Sage Therapeutics, LLC | $44.51 | 2024 | |
| Merck Sharp & Dohme LLC | $42.45 | 2023-2024 | Gardasil 9, Gardasil |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $38.77 | 2023-2025 | |
| Coopersurgical, INC. | $38.57 | 2023-2025 | Mara Console, Paragard T 380a |
| Coloplast Corp | $35.72 | 2021 | |
| Organon LLC | $33.00 | 2024-2025 | Nexplanon |
| Avion Pharmaceuticals | $28.77 | 2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $27.19 | 2024 | |
| Davol INC. | $22.43 | 2023 | Arista Ah Flexitip |
| Ethicon US, LLC | $18.92 | 2024 | Vistaseal |
| Millicent US INC | $17.80 | 2024 | Intrarosa |
| Medtronic, INC. | $16.57 | 2024 | Truclear |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Monard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.